EQUICLIN

By understanding the potential benefit of AI/ML and the power of lived experiences, underrepresented populations can be recruited using latest technologies to reduce health disparities and improve health outcomes. We are values-driven: At Equiclin, our values guide how we treat others, make decisions, and operate as a team. By being person-centred, socio-culturally sensitive, service-oriented, impact-driven and open to change, we enable our mission of increasing access, choice and equity.We guide the way, from concept through pre-clinical trials and post marketing research by our understanding of the lived experience and social construction of clinical research by underrepresented ethnic minorities. In designing and conducting pre-clinical trials and post marketing research with sponsors and partners, we keep under-represented populations at the heart of our approach to promote health equity. By using AI enabled technology and commitment to quality, we can develop context-specific approaches to recruit underrepresented populations in clinical research for Drugs and Biological Products research. With partners across Africa, Europe, Asia and America, we are the go to experts for Clinical Research Site Identification and Activation in sites across Ghana and Nigeria for all your Phase 4 Clinical Trials, Real-World Data (RWD) and Real-World Evidence (RWE) generation to monitor and evaluate the postmarked safety of your approved drugs.